Disclosed is a method of promoting the maturation of monocytes comprising
the administration of a reactive oxygen species (ROS) inhibitor or scavenger and
at least one monocyte maturation-promoting agent. A composition for promoting the
maturation of monocytes is likewise disclosed. The pharmaceutical composition includes
a compound effective to promote the maturation of monocytes and a ROS inhibitor
or scavenger combined in a pharmaceutically acceptable carrier.
